Out of 26 million Texans, you may have an idea to change the world. You may have had several ideas to change the world. But only a tiny minority of you pushed through the U.S. Patent office from application to successful patent. We've seen Texans change the world many times over. Jack Kilby did it with Texas Instruments in 1958 with the integrated circuit, causing the start of the digital revolution, which, in part, is why you can read these words over your electronic device.
Over the last few years, Texas Business has brought its feature: Texas Business Patent of the Day. This list is of the ones that were either extremely clever, odd or strange. One thing becomes apparent from these patents and the patent that runs daily in Texas Business—Texans have a unique mind set.
Though the history of the Corn Dog is disputed, the State Fair of Texas claims to have introduced the Corny Dog sometime between 1938 and 1942. As a paean to that invention that now sits in the freezer section of every grocery store in the southwest, here are the fried foods the State Fair of Texas has introduced, or tried to introduce, in the last seven years.
Don't get caught up with John Wayne religion. For one thing, he's not Texan. He's in some fine movies involving Texas, most notably The Searchers, but none of his movies can make the best cut of Texas movies. Here's the short list.
Unsung Texas Business Journalists Mention that one is a reporter, and there's a spark of interest. Mention that one is a business news reporter, and watch the eyes glaze over. Except to the players, business and economic journalists are unappreciated. While many wish to become sports reporters when they grow up, most do not realize that business journalists cover the Real Game. Mention that reporter covers business, and watch the eyes glaze over. A toast to these below on the short list and the numerous unnamed ones slogging away. Full Story » TexasBusiness.com
Best Texas Mexican Food: The Short List No, we're not going to debate the difference between Tex-Mex, Mex-Tex, Mexican and Texican food. Just know these establishments are the pinnacle of Texas Mexican fare. No brag, just fact. Full Story » TexasBusiness.com
Best Texas Burgers Texas Burgers. . While a hamburger is merely sustenance and gratification for a meal, the memory a good Texas burger can give rise to Homeric odes. The short list. Full Story » TexasBusiness.com
Repros Therapeutics Inc. of The Woodlands today announced it has received approval from the IRB approval to commence the low dose Proellex(R) study. Repros Therapeutics focuses on the development of oral small molecule drugs that treat male and female reproductive disorders.
An institutional review board (IRB), also known as an independent ethics committee (IEC) or ethical review board (ERB), is a committee that has been formally designated to approve, monitor, and review biomedical and behavioral research involving humans with the aim to protect the rights and welfare of the research subjects. In the United States, the Food and Drug Administration (FDA) and Department of Health and Human Services (specifically Office for Human Research Protections) regulations have empowered IRBs to approve, require modifications in planned research prior to approval, or disapprove research. An IRB performs critical oversight functions for research conducted on human subjects that are scientific, ethical, and regulatory.
The National Research Act of 1974 defines IRBs and requires them for all research that receives funding, directly or indirectly, from what was the Department of Health, Education, and Welfare at the time, and is now the Department of Health and Human Services (HHS). IRBs are themselves regulated by the Office for Human Research Protections (OHRP) within HHS.
Repros Therapeutics’ new low dose study is designed to explore both safety and effectiveness in an escalating dose fashion. The study will test 5 different doses of Proellex (1, 3, 6, 9 and 12 mg) with 1 mg being the first dose tested. In previous studies a 12.5 mg dose was well tolerated and yielded statistically significant efficacy signals for both uterine fibroids and endometriosis.
The company plans to report the results after each patient dosing group has completed the 10-week dosing period. Based on previous work the ompany anticipates that all five doses will be safe. Although the company believes that both the 1 and 3 mg dose will not yield any efficacy signal due to the low levels of projected absorbed drug, those doses were required by the FDA to assure patient safety at higher doses in light of the liver toxicity exhibited at 50 mg. Retros Therapeutics believes that roughly 80% of women at the 12 mg dose will exhibit changes in menstrual patterns that translate to clinical benefit for both uterine fibroids and endometriosis. The benefits expected are significant reduction in menstrual bleeding and reduction in menstrual pelvic pain. Since the Company does not have human experience at doses lower than 12.5 mg it is difficult to project what efficacy signal might be observed below 12 mg.
In addition to healthy volunteers the protocol allows for the recruitment of women with uterine fibroids, endometriosis, heavy menstrual bleeding or menstrual pelvic pain as these women should see benefit at an effective dose. Previously a dose of 12.5 mg Proellex achieved highly statistically significant results compared to placebo (p<0.0001) when assessing quality of life improvements and excessive menstrual bleeding in women with uterine fibroids. In a small study there was no statistical difference in reduction in pain scores in women with endometriosis when Proellex was compared to Lupron(R). Unlike Lupron, Proellex caused no change in markers of bone mineral density, a side effect which limits the duration that a woman can take Lupron, according to a statement issued by Retros Therapeutics. The company expects to commence dosing of the 1 mg cohort in August or early September. The Company believes it can have reportable data from the 12 mg group within roughly 18 months after starting the 1 mg subject group.
The Texas News Scrawl is a handy reference to stories Texas Business recommends from other news sources. Some of the stories that Texas Business currently suggests include: Pipeline ruling strengthens Texas private property rights; Texas Bowl seeks new title sponsor; Insult to Injury: Texas Workers’ Comp System Denies, Delays Medical Help; American Airlines continues to shed jobs; Chemical Safety Board shut out of West probe by ATF; America’s greatest threat: Unsafe work conditions; The West News proves the value of a great weekly newspaper in a community torn up with grief and chaos; and more.